BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Roche's Ying Ying Yeoh Explores the Power of Public-Private Partnerships in Shaping Healthcare's Future in Asia Pacific

Ying Ying Yeoh, a key figure at Roche, shares insights into the transformative impact of public-private partnerships (PPPs) on healthcare i...

November 29, 2023 | News

Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Appl...

November 27, 2023 | News

Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition

Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...

November 27, 2023 | News

Gilead and Kite Oncology Showcase Groundbreaking Analyses of Yescarta® CAR T-Cell Therapy

Gilead and Kite Oncology, announced that two poster presentations, covering results from two of the largest real-world analyses, will be presented during t...

November 03, 2023 | News

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

October 10, 2023 | News

Akeso and RemeGen Team Up for Gastric Cancer Therapy Study

On September 28, 2023, Akeso (9926.HK) announced that its subsidiary, Akeso Pharma, will collaborate with RemeGen (Yantai) Co., Ltd. (688331.SH/0...

October 02, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

September 25, 2023 | News

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...

September 22, 2023 | News

MGI Collaborates with National Cancer Centre Singapore for Asian Cancer Genomic Profiling

"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...

September 18, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Paige Partners with Microsoft to Create World's Largest Cancer-Fighting AI Model

Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images ...

September 08, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...

September 06, 2023 | News

HiRO Boosts G lobal Presence and Operations with Courante Oncology Acquisition

As a reputable boutique CRO with a strong track record of delivering high-quality, expedited clinical trials in the Asia-Pacific, HiRO's acquisit...

September 01, 2023 | News

Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea

SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...

August 28, 2023 | News

Stay Connected